Microsoft Word - Supplementary+material Drug Target Insights 2025 | DOI: 10.33393/dti.2025.3631 | Fanta et al Figure S1: HR-ESI-MS (-) spectrum of compound 1 Figure S2: 1H NMR spectrum of compound 1 Drug Target Insights 2025 | DOI: 10.33393/dti.2025.3631 | Fanta et al Figure S3: 13C NMR spectrum of compound 1 Figure S4: APT NMR spectrum of compound 1 Drug Target Insights 2025 | DOI: 10.33393/dti.2025.3631 | Fanta et al Figure S5: HMBC spectrum of compound 1  Figure S6: HMBC spectrum of compound 1 showing 5J correlation Drug Target Insights 2025 | DOI: 10.33393/dti.2025.3631 | Fanta et al Table S1. 1H, 13C NMR Data and correlation HMBC of Compounds 1 (CDCl3, 500 MHz) δ in ppm Position 1 𝜹C 𝜹H HMBC 1/12′ 144.9 - - 2/13′ 143.8 - - 3/14′ 114.3 6.83 (s, 2H) C-1, C-2, C-4, C-7/C-12′, C-13′, C-9′ 4/9′ 124.6 - - 5/10′ 131.7 - - 6/11′ 109.9 7.73 (s, 2H) C-1, C-2, C-4, C-5, C-4′/C-12′, C-13′, C-9′, C-10′, C-9 7/7′ 29.2 2.70 (m, 4H) C-3, C-4, C-5, C-8/C-8′, C-3′ 8/8′ 31.0 2.72 (m, 4H) C-7, C-9, C-14/C-10′, C-7′, C-4′ 9/4′ 115.2 - - 10/5′ 101.2 6.33 (d, 2H, J=2.5Hz) C-8, C-9, C-11, C-12/C4′, C-6′, C-1′, C-7′ 11/6′ 158.7 - - 12/1′ 106.7 6.44 (d, 2H, J=2.5Hz) C-10, C-11, C-13/C-5′, C-6′, C-2′ 13/2′ 153.1 - - 14/3′ 141.5 - - 11/6′-OCH3 55.4 3.80 (s, 6H) C-11/C-6′ 1/12′-OCH3 56.3 3.91 (s, 6H) C-1/ C-12′ 2/13′-OH - 5.62 (s, 2H) C-1, C-3/ C-12′, C-13′ 13/2′-OH 5.33 (s, 2H) C-13/C-2′ Figure S7. Diagrams determining inhibition percentage of antioxidant activities of extracts and isolated compounds according to DPPH and FRAP test 0 10 20 30 40 50 60 70 80 90 BHT 1 6 7 E. AcOEt E. MeOH % in hi b iti on Sample DPPH FRAP Drug Target Insights 2025 | DOI: 10.33393/dti.2025.3631 | Fanta et al Highlight  First chemical and pharmacological investigation of the twigs of Combretum molle  Isolation and characterizations of a new macrocyclic bisbibenzyl from C. molle  Potent antioxidant activities of extract and pure isolated compounds  Results are in agreement with the traditional health uses of the plant